OR52A1

Across TCGA pan-cancer cohorts, OR52A1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR52A1 data layer compared with 6 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR52A1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR52A1 expression acts as an unfavorable survival marker.

ACC, CESC, and UCS are the cancer types where OR52A1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.046	0.753	<.001	72	view →
CESC	OS	Tertile	III,IV	0.146	0.657	.015	36	view →
UCS	DFS	Tertile	All	0.072	0.533	<.001	36	view →
SKCM	OS	Tertile	IV	0.213	0.783	<.001	33	view →
BLCA	DFS	Tertile	All	0.149	0.355	.007	18	view →
GBM	DFS	Tertile	All	0.063	0.292	<.001	9	view →
THCA	DFS	Tertile	II,III,IV	0.438	0.734	.025	9	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	9	view →
KIRP	DFS	Tertile	All	0.770	0.923	.032	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR52A1–ACC (DFS)

Open the ACC breakdown →